Recombinant TNF alpha (Certolizumab Biosimilar) antibody
The Human Monoclonal anti-TNF alpha (Certolizumab Biosimilar) antibody (ABIN7675915) specifically detects TNF alpha (Certolizumab Biosimilar) in ELISA, FACS, BLI, Func and SPR.
The antibody is reactive with Human samples.
Catalog No. ABIN7675915
-15% Promotion 2026
$294.23
save $51.92 (-15 %)
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 10 to 11 Business Days
Quick Overview for Recombinant TNF alpha (Certolizumab Biosimilar) antibody (ABIN7675915)
Target
TNF alpha (Certolizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
Un-conjugated
Application
ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-TNFSF2 / TNFa Reference Antibody (certolizumAb)
-
Characteristics
- Anti-TNFSF2 / TNFa Reference Antibody (certolizumAb) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
-
Purity
- >95 %
-
Isotype
- IgG1
-
-
anti-TNF alpha (Certolizumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Humanized Monoclonal unconjugated
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- TNF alpha (Certolizumab Biosimilar)
-
Alternative Name
- TNFSF2 (Certolizumab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 145.5 kDa
-
UniProt
- P01375
Target
-
You are here:
